Xalkori - direct healthcare professional communication (DHPC)

crizotinib
DHPCHuman

Hungarian is available via eTranslation, the European Commission's machine translation service.

Translate to Hungarian | Important information about machine translation

Leírás

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Dokumentumok

Direct healthcare professional communication (DHPC): Xalkori (crizotinib): Vision disorders, including risk of severe visual loss, need for monitoring in paediatric patients

English (EN) (177.44 KB - PDF)

Első közzététel:
Megtekintés

Key facts

Medicine name
Xalkori
Active substance
crizotinib
Therapeutic area (MeSH)
Carcinoma, Non-Small-Cell Lung
Procedure number
EMEA/H/C/002489/II/0072
Regulatory outcome
Variation
DHPC type
Adverse event
Human ATC codes
L01ED01

Share this page